MiMedx Group, Inc. (NASDAQ:MDXG) Q3 2022 Earnings Conference Call November 2, 2022 5:00 PM ET Company Participants Matt Notarianni ??? Head-Investor Relations Todd Newton ??? Interim Chief Executive Officer Pete Carlson ??? Chief Financial Officer Rohit Kashyap ??? President-Wound and Surgical Robert Stein ??? President-Regenerative Medicine Conference Call Participants Anthony Petrone ??? Mizuho Group RK ??? H.C. Wainwright Carl Byrnes ??? Northland Capital John Vandermosten ??? Zacks Operator Good aftern ...

Q3:22 Financial Results 1 November 2, 2022 This presentation includes forward-looking statements. Forward-looking statements are subject to risks and uncertainties, and the Company cautions investors against placing undue reliance on such statements. Actual results may differ materially from those set forth in the forward-looking statements. Such forward-looking statements include statements regarding: • future sales or sales growth; • the effectiveness of amniotic tissue as a therapy for any particular ind ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Quarterly Period Ended September 30, 2022 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from _____________________to______________________ Commission File Number 001-35887 MIMEDX GROUP, INC. (Exact name of registrant as specified in its charter) Florida 26-2 ...

MiMedx Group, Inc. (NASDAQ:MDXG) Q2 2022 Earnings Conference Call August 3, 2022 8:30 AM ET Company Participants Jack Howarth ??? Senior Vice President-Investor Relations Tim Wright ??? Chief Executive Officer Pete Carlson ??? Chief Financial Officer Rohit Kashyap ??? President Wound Care and Surgical Robert Stein ??? President, Regenerative Medicine and Biologics Innovation Conference Call Participants Anthony Petrone ??? Mizuho Group RK ??? H.C. Wainwright Carl Byrnes ??? Northland Capital Markets John Va ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Quarterly Period Ended June 30, 2022 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from _____________________to______________________ Commission File Number 001-35887 MIMEDX GROUP, INC. (Exact name of registrant as specified in its charter) Florida 26-279255 ...

MiMedx Group, Inc. (NASDAQ:MDXG) Q1 2022 Earnings Conference Call May 4, 2022 8:30 AM ET Company Participants Jack Howarth - Senior Vice President, Investor Relations Tim Wright - Chief Executive Officer Pete Carlson - Chief Financial Officer Rohit Kashyap - Executive Vice President and Chief Commercial Officer Robert Stein - Executive Vice President, Research and Development Conference Call Participants Swayampakula Ramakanth - H.C. Wainwright Anthony Petrone - Mizuho Group Carl Byrnes - Northland Capital ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Quarterly Period Ended March 31, 2022 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from _____________________to______________________ Commission File Number 001-35887 MIMEDX GROUP, INC. (Exact name of registrant as specified in its charter) Florida 26-27925 ...

| --- | --- | --- | |---------------------------------|-------|-------| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | A TRANSFORMATIONAL | | | | PLACENTAL BIOLOGICS COMPANY | | | | Canaccord Genuity | | | | | | | | 2022 Musculoskeletal Conference | | | | | | | | March 22, 2022 | | | DISCLAIMER & CAUTIONARY STATEMENTS This presentation includes forward-looking statements. Forward-looking statements are subject to risks and uncertainties, and the Company cautions investors against ...

MiMedx Group, Inc. (NASDAQ:MDXG) Q4 2021 Earnings Conference Call February 28, 2022 5:00 PM ET Company Participants Jack Howarth - Senior Vice President, Investor Relations Tim Wright - Chief Executive Officer Pete Carlson - Chief Financial Officer Rohit Kashyap - Executive Vice President and Chief Commercial Officer Robert Stein - Executive Vice President, Research and Development Conference Call Participants Carl Byrnes - Northland Capital Markets Swayampakula Ramakanth - H.C. Wainwright John Vandermosten ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ☑ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2021 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from __________to __________ Commission file number 001-35887 MIMEDX GROUP, INC. (Exact name of registrant as specified in its charter) (State or other jurisdiction of incorporation ...